Anne Salomon
Overview
Explore the profile of Anne Salomon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peyrottes A, Masson-Lecomte A, Mongiat-Artus P, Nourieh M, Sirab N, Reyal F, et al.
Fr J Urol
. 2024 Sep;
34(13):102751.
PMID: 39305999
Introduction: Renal cell carcinoma (RCC) and breast carcinoma (BC) are frequent tumours, yet their co-occurrence in the same patient is a unique scenario. Few studies explored the characteristics of such...
2.
Ter Brugge P, Moser S, Bieche I, Kristel P, Ibadioune S, Eeckhoutte A, et al.
Nat Commun
. 2023 Apr;
14(1):1958.
PMID: 37029129
The high frequency of homologous recombination deficiency (HRD) is the main rationale of testing platinum-based chemotherapy in triple-negative breast cancer (TNBC), however, the existing methods to identify HRD are controversial...
3.
Hilmi M, Kamal M, Vacher S, Dupain C, Ibadioune S, Halladjian M, et al.
Eur J Cancer
. 2023 Mar;
183:152-161.
PMID: 36868056
Background: Data on the role of the microbiota in cancer have accumulated in recent years, with particular interest in intratumoral bacteria. Previous results have shown that the composition of intratumoral...
4.
Petak I, Kamal M, Dirner A, Bieche I, Doczi R, Mariani O, et al.
NPJ Precis Oncol
. 2021 Jun;
5(1):59.
PMID: 34162980
Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic...
5.
Floris G, Richard F, Hamy A, Jongen L, Wildiers H, Ardui J, et al.
J Natl Cancer Inst
. 2020 Nov;
113(2):146-153.
PMID: 33152071
Background: High levels of stromal tumor-infiltrating lymphocytes (sTIL) are associated with increased pathological complete response (pCR) rate and longer survival after neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) patients. Here,...
6.
Coussy F, El-Botty R, Chateau-Joubert S, Dahmani A, Montaudon E, Leboucher S, et al.
Sci Transl Med
. 2020 Feb;
12(531).
PMID: 32075943
Topoisomerase I (TOP1) inhibitors trap TOP1 cleavage complexes resulting in DNA double-strand breaks (DSBs) during replication, which are repaired by homologous recombination (HR). Triple-negative breast cancer (TNBC) could be eligible...
7.
Ramspott J, Bekkat F, Bod L, Favier M, Terris B, Salomon A, et al.
J Invest Dermatol
. 2018 Jul;
138(12):2625-2634.
PMID: 30048651
Several studies have emphasized the importance of immune composition of the melanoma microenvironment for clinical outcome. The contribution of IL4I1, a phenylalanine oxidase with immunoregulatory functions, has not been yet...
8.
Hequet D, Callens C, Gentien D, Albaud B, Mouret-Reynier M, Dubot C, et al.
PLoS One
. 2017 Oct;
12(10):e0185753.
PMID: 29045452
Purpose: The Prosigna® breast cancer prognostic gene signature assay identifies a gene-expression profile that permits the classification of tumors into subtypes and gives a score for the risk of recurrence...
9.
Mathiot C, Decaudin D, Klijanienko J, Couturier J, Salomon A, Dumont J, et al.
Diagn Cytopathol
. 2006 Jun;
34(7):472-8.
PMID: 16783780
The authors report a prospective study on 88 samples of superficial lesions (lymph nodes, skin nodules, and breast tumors), performed by fine-needle aspiration cytology (FNAC) in 74 patients, allowing (i)...